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Background:  Arterial stiffness and nighttime blood pressure (BP) are associated with target organ damage and they convey increased 
cardiovascular risk. We investigated whether aortic stiffening has either additive or synergistic effect with ambulatory BP load in new-onset 
microalbuminuria during follow-up.
Methods:  163 white hypertensive non-diabetic patients (52±10 years, 98 men, 59 smokers, body mass index=28.8±5.4Kg/m2) were 
prospectively studied for 6 years. All patients underwent 24-hour BP ambulatory monitoring and carotid-femoral pulse wave velocity (PWV) 
measurement with Complior SP. Metabolic profile, estimated creatinine clearance (eGFR) and echocardiographic measurements were performed 
at baseline and last outpatient clinic visit (follow-up: 4.5±0.89 years). Microalbuminuria was defined as ACR between either 20 or 30 (men and 
women respectively) and 300mg/g. All subjects were under optimal antihypertensive therapy complemented by vasoactive drugs where appropriate. 
Medication during the last 6-month period consisted of: renin-angiotensin system inhibitors (49%), diuretics (25%), calcium-channel blockers (20%), 
beta-blockers (13%), statins (16%) and antiplatelet agents (18%).
Results:  Baseline nighttime systolic and diastolic BP were 121±13 and 73±9mmHg, while the incidence of microalbuminuria was 13.5% 
(n=22). Between baseline and last visit there was a decrease in BMI by 1.9±4.1Kgr/m2, while PWV was increased by 1.83±1.37m/s (7.9±1.5 vs. 
9.6±1.5m/s). During follow-up, 24h systolic and diastolic BP were decreased by 12.7±9.1 and 8.2±6.2mmHg (130±12 vs.122±12 and 80±9 vs. 
75±8mmHg) respectively. In Cox regression models after adjustment for confounders, independent predictors (HR [95% CI]) of microalbuminuria 
were: baseline nighttime systolic BP, 1.034 [1.001-1.068], p=0.046, baseline PWV, 1.317 [1.048-1.654], p=0.018, and the interaction term of 
nighttime systolic BP x baseline PWV, 1.003 [1.001-1.004], p<0.001.
Conclusions:  Baseline nighttime systolic BP and PWV have an additive effect on the incidence of microalbuminuria suggesting that integrated 
stiffening measures may predict kidney damage in the early course of hypertension.
